Applying real-world data from expanded-access (“compassionate use”) patients to drug development
Our drug development process has produced many life-saving medications, but patients experiencing rare diseases and similar conditions often are left with limited options for treatment. For an approved treatment to be developed, research on a new candidate or existing drug must validate safety and e...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cambridge University Press
2023-01-01
|
| Schriftenreihe: | Journal of Clinical and Translational Science |
| Schlagworte: | |
| Online-Zugang: | https://www.cambridge.org/core/product/identifier/S2059866123006064/type/journal_article |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|